ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,346.99
      -0.11%
      US Tech 100
      18,488.00
      -0.25%
      Dow Jones
      38,798.99
      -0.22%
      Brent Oil
      79.395
      0.00%
      Bitcoin
      69,443.63
      0.16%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Clearmind Medicine Inc (CMND)

      7. Clearmind Medicine Inc (CMND) News

      CMND

      Clearmind Medicine (CMND)

      Clearmind Medicine Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CMND
      DateTimeSourceHeadlineSymbolCompany
      05/10/20244:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
      05/10/20248:24AMGlobeNewswire Inc.Clearmind Medicine Advances its Proprietary Psychedelic- Based Synthetic Alcohol Beverage ProductNASDAQ:CMNDClearmind Medicine Inc
      05/07/20244:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
      05/07/20247:46AMGlobeNewswire Inc.Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD TreatmentNASDAQ:CMNDClearmind Medicine Inc
      04/30/20244:15PMGlobeNewswire Inc.Clearmind Applies to Cease Being a Reporting Issuer in CanadaNASDAQ:CMNDClearmind Medicine Inc
      04/17/20247:49AMGlobeNewswire Inc.Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental DisordersNASDAQ:CMNDClearmind Medicine Inc
      04/10/20247:17AMGlobeNewswire Inc.Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating DisordersNASDAQ:CMNDClearmind Medicine Inc
      04/09/20248:07AMGlobeNewswire Inc.Clearmind Medicine CEO Issues Letter to ShareholdersNASDAQ:CMNDClearmind Medicine Inc
      03/19/20247:55AMGlobeNewswire Inc.Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in ChinaNASDAQ:CMNDClearmind Medicine Inc
      03/13/20248:14AMGlobeNewswire Inc.Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical TrialNASDAQ:CMNDClearmind Medicine Inc
      03/13/20247:30AMGlobeNewswire Inc.Clearmind Medicine Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities ExchangeNASDAQ:CMNDClearmind Medicine Inc
      02/27/20247:58AMGlobeNewswire Inc.Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine CompoundsNASDAQ:CMNDClearmind Medicine Inc
      02/27/20247:58AMGlobeNewswire Inc.SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine CompoundsNASDAQ:CMNDClearmind Medicine Inc
      02/23/20247:06AMGlobeNewswire Inc.Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use DisorderNASDAQ:CMNDClearmind Medicine Inc
      02/20/20247:14AMGlobeNewswire Inc.SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based CompoundsNASDAQ:CMNDClearmind Medicine Inc
      02/20/20247:14AMGlobeNewswire Inc.Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based CompoundsNASDAQ:CMNDClearmind Medicine Inc
      02/05/20247:51AMGlobeNewswire Inc.Clearmind Medicine Receives Patent Approval for its Psychedelic Based Treatment of Binge Behaviors in ChinaNASDAQ:CMNDClearmind Medicine Inc
      02/01/20248:15AMGlobeNewswire Inc.Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research CenterNASDAQ:CMNDClearmind Medicine Inc
      01/16/202411:19AMGlobeNewswire Inc.Clearmind Medicine Inc. Closes US$2.4 Million Registered Direct and Private PlacementNASDAQ:CMNDClearmind Medicine Inc
      01/11/20249:28AMGlobeNewswire Inc.Clearmind Medicine Inc. Announces Pricing of $2.4 Million Registered Direct and Private PlacementNASDAQ:CMNDClearmind Medicine Inc
      01/10/20247:18AMGlobeNewswire Inc.Clearmind Medicine Completed Type A Meeting with the FDANASDAQ:CMNDClearmind Medicine Inc
      01/04/20247:18AMGlobeNewswire Inc.SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based TreatmentsNASDAQ:CMNDClearmind Medicine Inc
      01/04/20247:18AMGlobeNewswire Inc.Clearmind Medicine and SciSparc Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic- Based TreatmentsNASDAQ:CMNDClearmind Medicine Inc
      12/14/20238:26AMGlobeNewswire Inc.Clearmind Medicine Announces It Is In Compliance with All Applicable Nasdaq Listing StandardsNASDAQ:CMNDClearmind Medicine Inc
      12/05/20238:47AMGlobeNewswire Inc.Clearmind Medicine Achieved Positive Results in Cocaine Addiction TreatmentNASDAQ:CMNDClearmind Medicine Inc
      12/01/20238:14AMGlobeNewswire Inc.Weight loss MEAI: Clearmind Medicine’s Novel Obesity Drug Showed Positive Results in a Pre-Clinical TrialNASDAQ:CMNDClearmind Medicine Inc
      11/28/20238:25AMGlobeNewswire Inc.Clearmind Medicine Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic- Based TreatmentNASDAQ:CMNDClearmind Medicine Inc
      11/27/20238:55AMGlobeNewswire Inc.Clearmind Medicine to Participate in Traditional vs. Novel Psychedelics Virtual Event with Leading Industry FiguresNASDAQ:CMNDClearmind Medicine Inc
      11/21/20238:15AMGlobeNewswire Inc.Clearmind Medicine Announces 1-for-30 Reverse Share SplitNASDAQ:CMNDClearmind Medicine Inc
      11/17/20234:15PMGlobeNewswire Inc.Clearmind Medicine Announces Receipt of Nasdaq Delisting Notice and Plan for Immediate RecomplianceNASDAQ:CMNDClearmind Medicine Inc
       Showing the most relevant articles for your search:NASDAQ:CMND